Robert Hariri, MD, PhD

CEO, Celgene Cellular Therapeutics


Dr. Hariri is a serial entrepreneur in two technology sectors:biomedicine and aerospace. The Founder and Chief Executive Officer of one of the world’s largest human cellular therapeutics companies, Dr. Hariri has pioneered the use of stem cells to treat a range of life threatening diseases. His activities and experience includes academic neurosurgeon at Cornell, businessman, military surgeon and aviator and aerospace innovator. Dr, Hariri has over 70 issued and pending patents, has authored over 100 published chapters, articles and abstracts and is most recognized for his discovery of pluripotent stem cells from the placenta and as a member of the team which discovered TNF (tumor necrosis factor). Dr. Hariri was recipient of the Thomas Alva Edison Award in 2007 and 2011, and has received numerous other honors for his many contributions to biomedicine and aviation. A jet-rated commercial pilot with thousands of hours of flight time in over 60 different military and civilian aircraft, Dr. Hariri is a founder and board member of the Rocket Racing League, an extreme aerospace corporation. Dr. Hariri serves on numerous Boards of Directors including Myos Corporation and Provista. Dr Hariri is a member of the Board of Visitors of the Columbia University School of Engineering & Applied Sciences and the Science & Technology Council of the College of Physicians and Surgeons, and is a member of the scientific advisory board for the Archon X PRIZE for Genomics, which is awarded by the X Prize Foundation. Dr. Hariri is also a Trustee of the Liberty Science Center and has been appointed Commissioner of Cancer Research by NJ Governor Christie. A member of the Intl Rugby League, Dr. Hariri is also a Board Member of the Somerset Patriots, a minor league baseball team.